OPKO Health completed enrollment in phase 2 trial evaluating RAYALDEE as treatment forsymptomatic COVID-19 outpatients
On Aug. 30, 2021, OPKO announced completion of enrollment in its Phase 2 trial with RAYALDEEﾮ as a…
-
-
NIH launched study of third COVID-19 vaccine dose in kidney transplant recipients
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
-
FDA approved treatment for chronic kidney disease
On Apr. 30, 2021, the FDA approved AstraZeneca’s Farxiga (dapagliflozin) oral tablets to reduce the risk of kidney…
-
Biotechnology | Cardiology | Disease | FDA | Therapeutics
FDA approved Aurinia Pharmaceuticals LUPKYNIS (voclosporin) for adults with active lupus nephritis
On Jan. 22, 2021, Aurinia Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) had approved LUPKYNISTM…
-
Aurinia and Lonza announced exclusive agreement for dedicated Voclosporin manufacturing capacity
On Dec. 15, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
-
Research confirmed obesity is a cause of kidney disease
On Nov. 4, 2020, scientists at the University of Oxford announced they had discovered that obesity can increase…
-
Aurinia announced European trial to evaluate antiviral activity of Voclosporin in kidney transplant recipients with COVID-19
On Oct. 27, 2020, Aurinia Pharmaceuticals announced the funding and initiation of an open-label exploratory trial evaluating the…
-
OPKO Health initiated clinical trial of RAYALDEE in COVID-19 patients
On Sept. 15, 2020, OPKO Health announce it had initiated a Phase 2 trial with RAYALDEEﾮ as a…
-
Kidney transplantation between people with HIV is safe, NIH study found
On Jul. 23, 2020, kidney transplantation from deceased donors with HIV to people living with both HIV and…
-
From lung scarring to heart damage, COVID-19 may leave lingering marks
On Jul. 8, 2020, scientists at the UC Berkeley-UCSF Joint Medical Program reported that for some individuals with…
-
Biotechnology | FDA | Oncology | Rare Disease | Therapeutics
Ultragenyx and Kyowa Kirin Announce U.S. FDA Approval of Crysvita® (burosumab) for Treatment of Tumor-Induced Osteomalacia
On Jun. 18, 2020, Ultragenyx Pharmaceutical and Kyowa Kirin announced that the U.S. Food and Drug Administration (FDA)…
-
FDA authorized OPKO Health clinical trial evaluating RAYALDEE in COVID-19 patients
On Jun. 1, 2020, OPKO Health announced the U.S. Food and Drug Administration (FDA) had authorized OPKO to…
-
Baxter announced results of clinical trial on benefits of Dynamic Fluid Management in septic shock patients
On May 6, 2020, Baxter announced results of the Fluid Response Evaluation in Sepsis Hypotension and Shock (FRESH)…
-
CareDx and Johns Hopkins partnered on AlloSure lung surveillance for severe COVID-19 patients
On Apr. 23, 2020, CareDx and Johns Hopkins University announced the launch of the ALARM (AlloSure Lung Allograft…
-
More than 5,000 lives touched by OHSU Kidney Transplant Program
On Jul. 24, 2019, the Oregon Health Science University (OHSU) Transplant Program – one of the oldest, largest…
-
FNIH Biomarkers Consortium and Critical Path Institute achieve qualification of a clinical safety biomarker
On Oct. 25, 2018, The Foundation for the National Institutes of Health, Biomarkers Consortium and the Critical Path…
-
Biotechnology | Diagnostics | Non-Profit Research | Oncology | Pharmaceutical | Radiology | Therapeutics
UNMC Renamed Eppley Cancer Center to the Fred & Pamela Buffett Cancer Center
In Jun. 7, 2013, the University of Nebraska Board of Regents approved changing the name of the UNMC…
-
The Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research opened
On Oct. 29, 2010, The Eli and Edythe Broad CIRM Center for Regenerative Medicine and Stem Cell Research…
-
1st U.S. patient walked out of the hospital without a human heart
On May 3, 2010, Charles Okeke became the first U.S. patient to be discharged from the hospital without…
-
Fraternal Order of Eagles announced a $25 million gift commitment to fund diabetes research at University of Iowa
On Sept. 16, 2008, leaders of The Fraternal Order of Eagles, the University of Iowa and the University…
-
World Kidney Day was established
On Mar. 8, 2006, World Kidney Day, a joint initiative between the International Society of Nephrology (ISN) and…
-
An international call-to-action issued to conduct the annual observance of World Lupus Day
On May 10, 2004, an international call-to-action has been issued by more than one hundred lupus organizations based…
-
Drs. Judith James and John Harley at the OMRF published an important study that showed certain antibodies for lupus were typically present years before the disease with diagnosed
On Oct. 16, 2003, scientists from the Oklahoma Medical Research Foundation (OMRF) and the University of Oklahoma Health…
-
NCI researchers reported that the molecularly targeted drug bevacizumab slowed tumor growth in patients with metastatic renal cell carcinoma
On May 19, 2002, researchers from the National Cancer Institute reported that the molecularly targeted drug bevacizumab slowed…
-
Genentech drug CellCept (mycophenolate mofetil) approved by FDA
On May 3, 1995, the U.S. Food & Drug Administration (FDA) announced it had approved Genentech’s drug CellCept…
-
First laparoscopic kidney removal to treat renal cancer was performed by Washington University – St Louis physicians
In 1990, Washington University – St. Louis physicians Ralph V. Clayman, MD, Lou Kavoussi, MD, and Nathaniel J….
-
First clinical tests conducted at UW of EPO to correct anemia of kidney failure
In Dec. 1985, the first clinical tests were held at the University of Washington of erythropoietin (EPO), the…
-
Amgen scientists isolated the gene that created erythropoietin (EPO)
In 1983, Amgen scientists, led by by Fu-Kuen Lin, isolated the gene that creates EPO and filed a…
-
Calvin Stiller conducted one of the first clinical trials studying the immunosuppressive drug cyclosporin for kidney transplants
In 1970, Dr. Calvin Stiller conducted one of the first clinical trials studying the effectiveness of the immunosuppressive…
-
Three rubella virus strains were licensed in the U.S.
In 1969, three rubella virus strains were licensed in the U.S.: HPV-77 strain grown in dog-kidney culture (Rubelogen…
